Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
暂无分享,去创建一个
P. Chiusolo | L. Pagano | G. Leone | G. Fadda | M. Caira | T. Spanu | R. Cauda | E. Trecarichi | M. Tumbarello | L. Fianchi